다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Vanda Pharmaceuticals Inc (VNDA)
Vanda Pharmaceuticals Inc (VNDA) 뉴스

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/01/30	09:00	PR Newswire (US)	Court Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag Hearing Request by March 5, 2024	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/01/26	12:05	PR Newswire (US)	Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/01/26	03:07	PR Newswire (US)	Vanda Pharmaceuticals announces the publication of an article on "The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial" in the Clinical Gastroenterology and Hepatology	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/01/24	01:52	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/01/23	23:15	PR Newswire (US)	Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/01/20	06:57	Dow Jones News	Vanda Pharma's Trade Secrets Suit Against FDA Moves Forward	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/01/20	05:56	PR Newswire (US)	Federal Court Allows Vanda Pharmaceuticals' Lawsuit to Proceed Against the U.S. Food and Drug Administration	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/01/18	05:46	PR Newswire (US)	Vanda Pharmaceuticals announces the publication of Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study in the Journal of Clinical Psychiatry	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/01/13	02:21	PR Newswire (US)	Vanda Pharmaceuticals Comments on FDA's Recently Announced Guidance on Communication with Health Care Professionals Regarding FDA-Approved Drugs	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/01/05	06:30	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/12/16	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/12/08	07:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/12/07	21:00	PR Newswire (US)	Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORY® (ponesimod), a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/12/05	20:23	Dow Jones News	Vanda Pharmaceuticals Shares Rise Premarket on FDA Review of Tradipitant	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/12/05	08:45	Dow Jones News	Vanda Pharma Says FDA Accepts New Drug Application for Tradipitant to Treat Gastroparesis	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/12/05	08:00	PR Newswire (US)	Vanda Pharmaceuticals Announces that U.S. Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/11/10	06:30	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at November 2023 Investor Conferences	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/11/09	21:04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/11/09	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/11/09	06:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Third Quarter 2023 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/11/02	06:00	PR Newswire (US)	Vanda Pharmaceuticals to Announce Third Quarter 2023 Financial Results on November 8, 2023	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/10/20	20:00	PR Newswire (US)	Vanda Pharmaceuticals Intends to Petition the U.S. Supreme Court in its HETLIOZ® ANDA Litigation	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/10/07	03:34	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/10/06	07:30	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation in the Jefferies Inaugural Biotech CNS/Neuro Summit	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/09/07	06:30	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/09/02	07:51	PR Newswire (US)	Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/08/24	05:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/08/22	06:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/08/22	06:07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/08/19	12:27	KR Market News	게임스톱 때보다 더 신중하지만 밈 주식 투자는 지속	NASDAQ:VNDA	Vanda Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 다음 >>

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관